Risk factor control, adherence to medication and follow up visit, five years after coronary artery bypass graft surgery

Arsalan Salari ¹, Tolou Hasandokht ^1,2 * , Marjan Mahdavi-Roshan ^1,2, Jalal Kheirkhah ¹, Mahboueh Gholipour ¹, Mahsa Pouradollah Tootkaoni ¹

Cited by CrossRef: 1

1- Paquette M, França L, Teutsch C, Diener H, Lu S, Dubner S, Ma C, Rothman K, Zint K, Halperin J, Olshansky B, Huisman M, Lip G, Nieuwlaat R. Dabigatran Persistence and Outcomes Following Discontinuation in Atrial Fibrillation Patients from the GLORIA-AF Registry. The American Journal of Cardiology. 2020;125(3):383 [Crossref]

2- Lei L, Li J, Zhang L, Yuan X, Diao X, Qi L, Wang Y, Du W, Zhao W, Hu S. Design and rationale of the artificial intelligent dialogue System assisted comprehensive Management of secondary prevention Among post coronary aRtery bypass graft patienTs (SMART): protocol for a randomised controlled trial for postcoronary artery bypass grafting management. BMJ Open. 2025;15(11):e106447 [Crossref]

3- Arslantürk O, Aydın A, Gümüş F, Aydın K, Zeybek D, Canpınar H, Güvener M. Unraveling the Mystery: How High Density Lipoprotein ‘Good’ Cholesterol Goes ‘Bad’?. Med J West Black Sea. 2024;8(2):177 [Crossref]

Platinum Open Access

This Platinum Open Access journal publishes articles totally free of charge for the authors and provides unrestricted access to the published content through its website and open access repositories such as PubMed Central. All related costs for processing of the manuscripts are sponsored by Tabriz University of Medical Sciences.

Indexing Info